HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.
Wednesday, 2 January 2013
Latest NICE topic for HEDS
Just to let you know ScHARR-TAG has been allocated the following topic:
Infliximab, adalimumab and golimumab for the treatment of second line sub-acute manifestations ulcerative colitis (Review TA140 & TA262) (MTA)